Traditional Chinese Herbal Products for Coronary Heart Disease: An Overview of Cochrane Reviews

Table 2

Registered Studies of TCHP for CHD in the Cochrane Central Register of Controlled Trials.

First author	TCHP	Condition	Participants	Random	Blinding of participants, personnel, or outcome assessors	Allocation concealment	Incomplete outcome data adequately addressed	Free of the suggestion of selective outcome reporting	Informed consents	Conclusion
Chu et al. [14]	Xuefu Zhuyu capsule	Unstable anginal patients after percutaneous coronary intervention	90	Yes but no details	Participants and doctor	Yes	Yes	Unclear	Yes	A+
Li et al. [15]	Specific TCHP	Myocardial perfusion in AMI patients after revascularization	80	Yes	Not mentioned	Not mentioned	Yes	Unclear	Yes	A+
Li et al. [16]	Specific TCHP	Ventricular wall motion in AMI patients after revascularization	80	Yes	Not mentioned	Not mentioned	Yes	Unclear	Unclear	A
Hu et al. [17]	Shenfu injection	Heart function in patients with chronic heart failure	63	Yes but no details	Not mentioned	Not mentioned	Unclear	Unclear	No	A+
Tam et al. [18]	Salvia miltiorrhiza and Pueraria lobata	Vascular function and structure in coronary patients	100	Yes	Double-blind but no details	Not mentioned	Yes	Yes	Yes	A+
Qiu et al. [19]	Specific TCHP	The clinical symptoms and quality of life of the AMI patients undergoing PCI	35	Yes	Participants and doctor	Not mentioned	Yes	No	Unclear	A+
Fan et al. [20]	Qihong decoction	Rehabilitation of patients after coronary artery bypass	72	Yes	Not mentioned	Not mentioned	No	No	No	A+
Wang et al. [21]	Shenshao tablet	The quality of life for CHD patients with UA	66	Yes	Participants and doctor	Not mentioned	Yes	Unclear	Yes	A+

Notes: A+: TCHP has definitely effect.
A: TCHP may be or appears to be effective.